Near-Infrared Fluorescence Imaging with Indocyanine Green to Evaluate Bowel Anastomoses in Gynecologic Oncology Surgery
Launched by ISTANBUL UNIVERSITY · Mar 6, 2025
Trial Information
Current as of April 23, 2025
Not yet recruiting
Keywords
ClinConnect Summary
In gynecologic cancer surgeries, complete removal of the tumor often requires bowel resection (removal of part of the intestine). After resection, surgeons perform bowel anastomosis to restore gastrointestinal continuity. However, anastomosis can sometimes fail, leading to complications such as leaks, pelvic abscesses, or infections. Such complications significantly affect patient health, recovery, and outcomes.
Indocyanine green (ICG) is a dye approved by health authorities for clinical use. When injected into the bloodstream, it glows brightly under near-infrared (NIR) light, allowing in...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Female patients aged 18 years or older.
- • Diagnosis of gynecologic cancer (ovarian, endometrial, cervical, vulvar) requiring surgical treatment.
- • Planned bowel resection and anastomosis during gynecologic oncology surgery.
- • Ability and willingness to provide informed consent.
- Exclusion Criteria:
- • Known allergy or hypersensitivity to indocyanine green (ICG).
- • Pregnancy or breastfeeding at the time of surgery.
- • Severe liver or kidney dysfunction limiting the use of ICG.
Trial Officials
Samet Topuz, Prof.
Study Chair
Istanbul University
Yagmur Minareci, Assist. Prof.
Study Director
Istanbul University
About Istanbul University
Istanbul University, a leading institution in Turkey, is dedicated to advancing healthcare through rigorous clinical research and education. Renowned for its commitment to scientific excellence and innovation, the university sponsors clinical trials that aim to enhance medical knowledge and improve patient outcomes. With a diverse team of researchers and healthcare professionals, Istanbul University fosters collaboration across disciplines to explore new therapeutic interventions and contribute to global health advancements. Its robust infrastructure and ethical standards ensure the highest quality in clinical trial management, making it a key player in the field of medical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Istanbul, , Turkey
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Related Blog Entries
View all
